Skip to main content
SpringerLink
Log in

A two-dose pneumococcal polysaccharide vaccine strategy is the treatment of choice for the prevention of invasive pneumococcal disease,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Zimmerman RK, Smith K, Roberts M.Vaccination to prevent invasive pneumococcal disease: what age to start and how often? A decision analysis. 44th Annual Meeting of the Infectious Diseases Society of America: abstr. LB-38, 12 Oct 2006. Available from: URL: http://www.idsociety.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A two-dose pneumococcal polysaccharide vaccine strategy is the treatment of choice for the prevention of invasive pneumococcal disease,. Pharmacoecon. Outcomes News 517, 6 (2006). https://doi.org/10.2165/00151234-200605170-00012

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605170-00012

Keywords

Search

Navigation